Ian D Lewis

Ian D Lewis

UNVERIFIED PROFILE

Are you Ian D Lewis?   Register this Author

Register author
Ian D Lewis

Ian D Lewis

Publications by authors named "Ian D Lewis"

Are you Ian D Lewis?   Register this Author

49Publications

1753Reads

38Profile Views

Prospective, Randomized, Double-Blind, Phase III Clinical Trial of Anti-T-Lymphocyte Globulin to Assess Impact on Chronic Graft-Versus-Host Disease-Free Survival in Patients Undergoing HLA-Matched Unrelated Myeloablative Hematopoietic Cell Transplantation.

J Clin Oncol 2017 Dec 17;35(36):4003-4011. Epub 2017 Oct 17.

Robert J. Soiffer, Haesook T. Kim, Vincent T. Ho, Edwin P. Alyea, and Jerome Ritz, Dana-Farber Cancer Institute; James D. Levine, Beth Israel Deaconess Medical Center and Harvard Medical School; Yi-Bin Chen, Massachusetts General Hospital, Boston; Frank Glavin, Neovii Biotech, Lexington, MA; Joseph McGuirk, University of Kansas Medical Center, Kansas City, KS; Mitchell E. Horwitz, Duke University Medical Center, Durham; Thomas C. Shea, University of North Carolina School of Medicine, Chapel Hill, NC; Laura Johnston, Stanford University, Stanford, CA; Mrinal M. Patnaik, Mayo Clinic, Rochester, MN; Witold Rybka, Penn State College of Medicine, Hershey; David L. Porter, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA; Andrew Artz, University of Chicago, Chicago; Patrick J. Stiff, Loyola University Medical Center, Maywood, IL; Michael W. Boyer, University of Utah, Salt Lake City, UT; Richard T. Maziarz, Oregon Health & Science University, Portland, OR; Paul J. Shaughnessy, Texas Transplant Institute, San Antonio; Madhuri Vusirikala, University of Texas Southwestern Medical Center, Dallas, TX; Usama Gergis, Weill Cornell Medical College; Ran Reshef, Columbia University Medical Center, New York, NY; Hana Safah, Tulane University, New Orleans, LA; John F. DiPersio and Peter Westervelt, Washington University School of Medicine, St Louis, MO; Jeff Szer, Royal Melbourne Hospital, Parkville, Victoria; Ian D. Lewis, Royal Adelaide Hospital, Adelaide, South Australia, Australia; Jennifer Holter, University of Oklahoma Health Sciences Center, Oklahoma City, OK; Paul J. Martin, Fred Hutchinson Cancer Research Center, Seattle, WA; Joseph A. Pidala, H. Lee Moffitt Cancer Center, Tampa, FL; and Madan H. Jagasia, Vanderbilt University Medical Center, Nashville, TN.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.75.8177DOI Listing
December 2017

Idarubicin Dose Escalation During Consolidation Therapy for Adult Acute Myeloid Leukemia.

J Clin Oncol 2017 May 3;35(15):1678-1685. Epub 2017 Apr 3.

Kenneth F. Bradstock and Warwick Benson, Westmead Hospital, University of Sydney; Arno Enno, Sandra Deveridge, and Philip Rowlings, Calvary Mater Newcastle Hospital, Newcastle; Luke Coyle, Royal North Shore Hospital, St Leonards; Campbell Tiley, Central Coast Health, Gosford; John Moore, St Vincent's Hospital; Mark Hertzberg, Prince of Wales Hospital, Sydney; Kimberly Cartwright, Wollongong Hospital, Wollongong; Ilona Cunningham, Concord Repatriation General Hospital, Concord; John Taper, Nepean Hospital, Penrith, New South Wales; Emma Link, Juliana Di Iulio, and John F. Seymour, Peter MacCallum Cancer Centre; Jeff Szer, Andrew Grigg, Andrew W. Roberts, and John F. Seymour, University of Melbourne; Andrew H. Wei, Monash University; Anthony Schwarer, Box Hill Hospital; Lynda Campbell, Victorian Cancer Cytogenetics Service, Melbourne; Jeff Szer, Andrew Grigg, and Andrew W. Roberts, Royal Melbourne Hospital, Parkville; Phillip Campbell, Deakin University School of Medicine, Geelong, Victoria; Paula Marlton, Anthony K. Mills, and Devinder Gill, University of Queensland, Brisbane, Queensland; Ray M. Lowenthal, University of Tasmania, Hobart, Tasmania; Ian D. Lewis and Peter Bardy, Royal Adelaide Hospital; Uwe Hahn, Queen Elizabeth Hospital, Adelaide, South Australia; James D'Rozario, The Canberra Hospital, Garran, Canberra, Australia Capital Territory; Gavin Cull, Sir Charles Gairdner Hospital; Michael F. Leahy, University of Western Australia; and Paul Cannell, Royal Perth Hospital, Perth, Western Australia, Australia.

View Article

Download full-text PDF

Source
http://ascopubs.org/doi/10.1200/JCO.2016.70.6374
Publisher Site
http://dx.doi.org/10.1200/JCO.2016.70.6374DOI Listing
May 2017

GD2-specific CAR T Cells Undergo Potent Activation and Deletion Following Antigen Encounter but can be Protected From Activation-induced Cell Death by PD-1 Blockade.

Mol Ther 2016 Jun 29;24(6):1135-1149. Epub 2016 Mar 29.

Translational Oncology Laboratory Centre for Cancer Biology, SA Pathology, and University of South Australia, Adelaide, South Australia; Discipline of Medicine, University of Adelaide, Adelaide, South Australia; Cancer Clinical Trials Unit, Royal Adelaide Hospital, Adelaide, South Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/mt.2016.63DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4923328PMC
June 2016

Novel germ line DDX41 mutations define families with a lower age of MDS/AML onset and lymphoid malignancies.

Blood 2016 Feb 28;127(8):1017-23. Epub 2015 Dec 28.

Department of Genetics and Molecular Pathology, Centre for Cancer Biology, SA Pathology, Adelaide, SA, Australia; School of Pharmacy and Medical Sciences, Division of Health Sciences, University of South Australia, Adelaide, SA, Australia; School of Medicine, University of Adelaide, Adelaide, SA, Australia; School of Molecular and Biological Sciences, University of Adelaide, Adelaide, SA, Australia; Australian Cancer Research Foundation Cancer Genomics Facility, Centre for Cancer Biology.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2015-10-676098DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968341PMC
February 2016

Vosaroxin is a novel topoisomerase-II inhibitor with efficacy in relapsed and refractory acute myeloid leukaemia.

Expert Opin Pharmacother 2015 Jun 10;16(9):1395-402. Epub 2015 May 10.

Royal Adelaide Hospital, Leukaemia Fellow, SA Pathology , Adelaide, SA 5000 , Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/14656566.2015.1044437DOI Listing
June 2015

Interleukin-3-mediated regulation of β-catenin in myeloid transformation and acute myeloid leukemia.

J Leukoc Biol 2014 Jul 5;96(1):83-91. Epub 2014 Mar 5.

Centre for Cancer Biology and School of Molecular and Biomedical Science and Centre for Stem Cell Research and Departments of Haematology and Department of Pharmacy and Medical Sciences, The University of South Australia, Adelaide, South Australia, Australia School of Medicine, The University of Adelaide, Adelaide, South Australia, Australia;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1189/jlb.2AB1013-559RDOI Listing
July 2014

An optimized algorithm for detecting and annotating regional differential methylation.

BMC Bioinformatics 2013 10;14 Suppl 5:S10. Epub 2013 Apr 10.

Department of Physiology and Biophysics,Weill Cornell Medical College, 1305 York Ave., New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2105-14-S5-S10DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3622633PMC
December 2013

Post-transplant plasmablastic lymphoma of the skin.

Australas J Dermatol 2013 Nov 17;54(4):277-82. Epub 2012 Aug 17.

Department of Dermatology, Royal Adelaide Hospital, Adelaide, South Australia, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1440-0960.2012.00939.xDOI Listing
November 2013

The granulocyte-associated transcription factor Krüppel-like factor 5 is silenced by hypermethylation in acute myeloid leukemia.

Leuk Res 2012 Jan 11;36(1):110-6. Epub 2011 Oct 11.

Centre for Cancer Biology and Department of Haematology, SA Pathology, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.leukres.2011.09.013DOI Listing
January 2012

Outcomes of lymphoma in South Australia, 1977-2007.

Med J Aust 2012 Jan;196(1):54-7

Haematology Directorate, SA Pathology and Haematology Unit, Royal Adelaide Hospital, Adelaide, SA. Brendon.Kearney@ health.sa.gov.au

View Article

Download full-text PDF

Source
https://www.mja.com.au/system/files/issues/196_01_160112/kea
Web Search
http://dx.doi.org/10.5694/mja11.10002DOI Listing
January 2012

Potential therapeutic applications of mesenchymal stromal cells.

Pathology 2011 Oct;43(6):592-604

Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAT.0b013e32834ab72dDOI Listing
October 2011

Cotransplantation of placental mesenchymal stromal cells enhances single and double cord blood engraftment in nonobese diabetic/severe combined immune deficient mice.

Stem Cells 2009 Sep;27(9):2293-300

Department of Haematology, Centre for Cancer Biology, SA Pathology, Adelaide, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/stem.157DOI Listing
September 2009

Potential for clinical ex vivo expansion of cord blood haemopoietic stem cells using non-haemopoietic factor supplements.

Curr Stem Cell Res Ther 2007 Sep;2(3):229-37

Division of Haematology and Hanson Institute, Institute of Medical and Veterinary Science, Adelaide, 5000, South Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/157488807781696221DOI Listing
September 2007

Bone morphogenetic protein 4 contributes to the maintenance of primitive cord blood hematopoietic progenitors in an ex vivo stroma-noncontact co-culture system.

Stem Cells Dev 2006 Dec;15(6):805-13

Haematology and Oncology Program, Child Health Research Institute, The Queen Elizabeth Hospital and the Schools of Paediatrics and Reproductive Health and Molecular and Biomedical Science, University of Adelaide, Adelaide, South Australia, 5006.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/scd.2006.15.805DOI Listing
December 2006

Pegfilgrastim to support CHOP-14 in elderly patients with non-Hodgkin's lymphoma.

Leuk Lymphoma 2006 Nov;47(11):2344-50

Division of Haematology & Medical Oncology, Peter MacCallum Cancer Centre, East Melbourne, VIC, Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/10428190600881017DOI Listing
November 2006

BMP4: its role in development of the hematopoietic system and potential as a hematopoietic growth factor.

Stem Cells 2004 ;22(4):457-74

Immunology Program, Child Health Research Institute, North Adelaide, South Australia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/stemcells.22-4-457DOI Listing
March 2005

Homing defect of cultured human hematopoietic cells in the NOD/SCID mouse is mediated by Fas/CD95.

Exp Hematol 2003 Sep;31(9):824-32

Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minn., USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0301-472x(03)00161-9DOI Listing
September 2003